The exclusive use of coagulation factor concentrates enables reversal of coagulopathy and decreases transfusion rates in patients with major blunt trauma-Reference-Cited by-同舟云学术

The exclusive use of coagulation factor concentrates enables reversal of coagulopathy and decreases transfusion rates in patients with major blunt trauma

Published:2013-02 Issue:2 Volume:44 Page:209-216
ISSN:0020-1383
Container-title:Injury
language:en
Short-container-title:Injury

Author:

Innerhofer Petra,Westermann Isabella,Tauber Helmuth,Breitkopf Robert,Fries Dietmar,Kastenberger Tobias,El Attal Rene,Strasak Alexander,Mittermayr Markus

Publisher

Elsevier BV

Subject

Orthopedics and Sports Medicine,Emergency Medicine

Reference36 articles.

1. The coagulopathy of trauma: a review of mechanisms;Hess;Journal of Trauma,2008

2. What's new in resuscitation strategies for the patient with multiple trauma?;Curry;Injury,2012

3. Guidelines on the management of massive blood loss;Stainsby;British Journal of Haematology,2006

4. Management of bleeding following major trauma: an updated European guideline;Rossaint;Critical Care,2010

5. Coagulation management in trauma-related massive bleeding. Recommendations of the Task Force for Coagulation (AGPG) of the Austrian Society of Anesthesiology. Resuscitation and Intensive Care Medicine (OGARI);Fries;Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie,2010

Cited by 123 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hemostatic effect of fibrinogen concentrate on traumatic massive hemorrhage: a propensity score matching study;Trauma Surgery & Acute Care Open;2024-01

2. The Most Important Questions in the Current Practice of Transfusion of Critically Bleeding Patients;Annual Update in Intensive Care and Emergency Medicine 2023;2023

3. Viscoelastic Hemostatic Tests and Fibrinogen Concentrations in Trauma;Biomarkers in Trauma, Injury and Critical Care;2023

4. The CRYOSTAT2 trial: The rationale and study protocol for a multi‐Centre, randomised, controlled trial evaluating the effects of early high‐dose cryoprecipitate in adult patients with major trauma haemorrhage requiring major haemorrhage protocol activation;Transfusion Medicine;2022-11-02

5. The Choice between Plasma-Based Common Coagulation Tests and Cell-Based Viscoelastic Tests in Monitoring Hemostatic Competence: Not an either–or Proposition;Seminars in Thrombosis and Hemostasis;2022-09-29